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Received November 14, 2013; accepted May 2, 2014AbstractBackground: Caffeate derivatives have been reported to exhibit antioxidant, anti-inflammatory, and anticancer activities. To reveal the cytotoxic
and apoptotic effects of caffeate derivatives, we studied the effects of octyl, phenylpropyl, and decyl caffeates on cell growth and apoptosis in
A549 human lung carcinoma cells.
Methods: A549 human lung carcinoma cells were treated with 0e100 mM of caffeate derivatives for 0e48 hours. The cytotoxic and apoptotic
effects were evaluated by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay for cell viability, propidium iodide
staining method for cell morphology, mitochondrial membrane potential analysis, and Western blot for protein expression.
Results: Octyl, phenylpropyl, and decyl caffeates all significantly decreased the cell viability of A549 cells with 50% inhibitory concentration
values of 54.2 ± 10.1 mM, 80.2 ± 1.3 mM, and 74.9 ± 2.1 mM, respectively. Propidium iodide staining revealed that apoptotic bodies appeared
when cells were treated with octyl and decyl caffeates. Treatment of A549 cells with octyl and decyl caffeates caused the loss of mitochondria
membrane potential. Western blots revealed that octyl and decyl caffeates stimulate an increase in the protein levels of Fas, FasL, and Apaf-1.
Moreover, these compounds changed the levels of pro- and antiapoptotic Bcl-2 family members and induced the activation of caspase-12, -9, and
-3, which was followed by cleavage of poly (ADP-ribose) polymerase.
Conclusion: These results demonstrate that octyl and decyl caffeates induce cell apoptosis in A549 human lung carcinoma cells.
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Lung cancer is the most lethal of all cancers worldwide and
has a dismal prognosis. It can be divided into two types, small-
cell lung cancer and nonesmall-cell lung cancer. Lung cancer
is the most common source of brain metastases in adult pa-
tients, which occurs in 30e50% of total lung cancer cases.1
Nonesmall-cell lung cancer is the most common type of
lung cancer (accounting for 80% of total lung cancer cases)ociation. All rights reserved.
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noma, squamous cell carcinoma, and large-cell carcinoma.2
Resistance to anticancer agents is a significant problem and
is observed frequently in the treatment of patients with small-
cell lung cancer and nonesmall-cell lung cancer.3
To date, phytochemicals and their derivatives have played
an important role in anticancer drug development. Caffeic acid
and some of its derivatives, such as caffeic acid phenethyl
ester (CAPE) have been reported to exhibit antioxidant, anti-
inflammatory, and anticancer activities.4 The preincubation
of caffeate derivatives (including CAPE, methyl caffeate, ethyl
caffeate, butyl caffeate, octyl caffeate, and benzyl caffeate)
inhibited nitric oxide (NO) production in lipopolysaccharide-
induced RAW 264.7 macrophages,5 which demonstrates
their in vivo anti-inflammatory properties. Uwai et al6 found
that the alkyl side-chain of caffeate derivatives inhibited NO
production in lipopolysaccharide -induced RAW 264.7 mac-
rophages. Ujibe et al7 indicated that octyl caffeate induced
apoptosis in human leukemia U937 cells through the induction
of caspase-3 activity and the fragmentation of nuclei and
DNA. Fiuza et al8 found that propyl caffeate and octyl caffeate
have an inhibitory effect on cell growth in human cervix
adenocarcinoma cells (HeLa). Nagaoka et al9 indicated that
the oral administration (2 mg/mouse/day) of CAPE, 4-
phenylbutyl caffeate, 8-phenyl-7-octenyl caffeate, 2-
cyclohexylethyl caffeate, and n-octyl caffeate caused a 55%,
43%, 55%, and 35% reduction in the formation of lung
metastasis tumor nodules, respectively. Kudugunti et al10
showed that CAPE induces apoptosis in SK-MEL-28 human
melanoma cells through quinone formation, reactive oxygen
species formation, intracellular GSH depletion, and induced
mitochondria toxicity. Lin et al11 indicated that caffeic acid
induced apoptosis in lung cancer cells through the NF-kB
pathway. However, the literature remains unclear regarding the
anticancer activity of octyl caffeate, phenylpropyl caffeate,
and decyl caffeate in A549 human lung cancer cells.
The objective of this study was to investigate the ability of
octyl caffeate, phenylpropyl caffeate, and decyl caffeate to
induce apoptosis in A549 human lung carcinoma cells and to
examine the chemotherapeutic potential of these derivatives
against lung cancer. The effects of caffeate derivatives on
intrinsically and extrinsically mediated apoptosis-induction
pathways in A549 human lung carcinoma cells were also
investigated.
2. MethodsOR2.1. Materials
HO
O
Octyl caffeate: R = C8H17
Phenylpropyl caffeate: R = (CH2)3Ph 
Decyl caffeate: R = C10H21
Fig. 1. The chemical structures of caffeate derivatives.Octyl caffeate, phenylpropyl caffeate, and decyl caffeate
were provided and synthesized by Professor Yueh-Hsiung Kuo
(Tsuzuki Institute for Traditional Medicine, College of Phar-
macy, China Medical University, Taichung, Taiwan). Syntheses
of caffeate derivatives were obtained from the caffeic acid and
thionyl chloride in dry dichloromethane, and ROH and trie-
thylamine were added as a reaction solution. The reaction
mixture was partitioned between ethyl acetate and H2O, and theethyl acetate layer was washed and dried. The synthetic com-
poundwas purified by column chromatography on silica gel and
recrystallized from acetone to obtain pure crystals. A Bruker
Avance DRX-500 spectrometer (Ettlingen, Germany) was used
to record 1H-nuclear magnetic resonance spectra. Electron
impact mass spectra were determined on a Finnigan TSQ-46C
mass spectrometer (Waltham, CA, USA). Infrared spectra were
recorded on a Nicolet Mangna-IR 550 spectrophotomer
(Madison, AL, USA). The chemical structures of octyl caffeate,
phenylpropyl caffeate, and decyl caffeate are shown in Fig. 1.
Sodium bicarbonate, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) dye, and propidium io-
dide (PI) were purchased from the Sigma Chemical Co. (St
Louis, MO, USA). Dimethylsulfoxide was purchased from the
Merck Co. (Darmstadt, Germany). RPMI 1640 medium, fetal
bovine serum, nonessential amino acids, L-glutamine, sodium
pyruvate and the antibiotic mixture (penicillinestreptomycin)
were purchased from Invitrogen (Carlsbad, CA, USA). Anti-b-
actin, anti-Fas, anti-FasL, anti-AIF (apoptosis-inducing factor),
anti-Apaf-1 (apoptotic protease activating factor-1), anti-Fas-
associated death-domain-like IL-1b-converting enzyme-
inhibitory protein (FLIP), anti-Bcl-2, anti-Bax, anti-Bad, anti-
caspase-12, anti-caspase-9, anti-caspase-3, and anti-PARP
[poly-(ADP-ribose) polymerase] antibodies were purchased
from BioVision (Mountain View, CA, USA). Anti-rabbit or
anti-mouse secondary horseradish peroxidase antibodies were
purchased from Bethyl Laboratories (Montgomery, TX, USA).
Protein molecular mass markers were obtained from Pharmacia
Biotech (Saclay, France). Polyvinyldifluoride membrane for
Western blotting was obtained from Perkin-Elmer Life Science
(Boston, MA, USA). All other chemicals were reagent grade.2.2. Cell cultureA549 human lung carcinoma cells were obtained from the
Bioresource Collection and Research Center (Food Industry
Research and Development Institute, Hsinchu, Taiwan). A549
cells were grown in a culture medium (90% RPMI 1640, 10%
fetal bovine serum, 0.1 mM nonessential amino acid, 2 mM
L-glutamine, 1 mM sodium pyruvate, and 100 units/mL
penicillin and streptomycin) and incubated at 37C in a hu-
midified incubator with 5% CO2.
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first described by Mosmann.12 A549 cells were plated into 96-
well microtiter plates at a density of 104 cells/well. After 24
hours, culture medium was replaced by 200 mL serial dilutions
(0e250 mM) of caffeate derivatives (including octyl caffeate,
phenylpropyl caffeate, and decyl caffeate), and the cells were
incubated for 24e48 hours. Culture medium was removed and
replaced with 90 mL fresh culture medium. A 10-mL aliquot of
MTT solution (5 mg/mL) was added to each well reaching a
final concentration of 0.5 mg/mL. After 3 hours, unreacted dye
was removed, and the insoluble formazan crystals were dis-
solved in 200 mL dimethylsulfoxide/well and measured spec-
trophotometrically in a VersaMax tunable microplate reader
(Molecular Devices, Sunnyvale, CA, USA) at 570 nm. The
relative cell viability (%) compared to the control (i.e., cells
cultured without the caffeate derivatives) was calculated by:
A570nm½sample=A570nm½control  100: ð1Þ
The 50% inhibitory concentration (IC50) value was calcu-
lated as the concentration of the caffeate derivative at which
cell growth was inhibited by 50% compared to the untreated
controls.2.4. Nuclear staining with PIA549 cells were stimulated with 0e50 mM of caffeate de-
rivatives for 48 hours. PI-stained cells were fixed with 80%
ethanol for 30 minutes and incubated with 40 mg/mL PI so-
lution for 30 minutes in the dark. The nuclear morphology of
the cells was examined using a Motic AE31 inverted micro-
scope with epi-fluorescence microscopy.2.5. Mitochondria membrane potential assayMitochondria membrane potential assays were performed
using the JC-1 mitochondria membrane potential assay kit
(Cayman Chemical Co., Ann Arbor, MI, USA). A549 cells
were seeded in 12-well plates. After 24 hours, the cells were
treated with 0e50 mM of caffeate derivatives for 0e12 hours.
The cells were then labeled with JC-1 according to the man-
ufacturer's instructions. Thereafter, the cells were resuspended
in adequate same solution and analyzed using a Flexstation 3
fluorescence plate reader (Molecular Devices) with an exci-
tation wavelength of 560 nm and the emission wavelength of
595 nm for red fluorescence. Apoptotic cells will generate a
lower reading of red fluorescence, and the changes in the
mitochondria membrane potential (DJm) can be assessed by
comparing the red fluorescence of untreated cells and cells
treated with caffeate derivatives.2.6. Western blot analysisA549 cells (107 cells/10 cm dish) were incubated with
25 mM of caffeate derivatives for 0 hours, 1 hour, 3 hours, 6
hours, 9 hours, 12 hours, and 24 hours. Cells were collectedand lysed in ice-cold lysis buffer to determine the protein
concentration (Bio-Rad DC protein assay, Bio-Rad Labora-
tories, Hercules, CA, USA). The Fas, FasL, AIF, Apaf-1, FLIP,
Bcl-2, Bax, Bad, caspase-12, -9, -3, PARP, and b-actin pro-
teins were assessed in A549 cells. Total proteins (50e60 mg)
were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis using a 12% polyacrylamide gel. The proteins
in the gel were transferred to a polyvinyldifluoride membrane
and then blocked with 5% skim milk in PBST (0.05% v/v
Tween-20 in phosphate buffered saline, pH 7.2) for 1 hour.
Membranes were incubated with primary antibody (1:1000) at
4C overnight and then with secondary antibody (1:2000) for 1
hour. Membranes were washed three times in PBST for 10
minutes between each step. The signal was detected using
enhanced chemiluminescence (ECL; Perkin-Elmer Life Sci-
ence, Boston, MA, USA).2.7. Statistical analysisData are presented as the mean ± standard deviation for the
indicated number of independently performed experiments.
Significant differences ( p < 0.05) between the groups were
calculated using Student unpaired t test.
3. Results3.1. Effects of caffeate derivatives on the viability of
A549 cellsThe chemical structures of octyl caffeate, phenylpropyl
caffeate, and decyl caffeate are shown in Fig. 1. To assess
whether these three caffeate derivatives (octyl caffeate, phe-
nylpropyl caffeate, and decyl caffeate) could inhibit the
viability of A549 human lung carcinoma, cells were treated
with 0e100 mM caffeate derivatives for 0e48 hours, and cell
viability was determined via the MTT assay. The effects of
octyl caffeate, phenylpropyl caffeate, and decyl caffeate on
cell viability in A549 cells are shown in Table 1. The results
indicate that addition of octyl caffeate, phenylpropyl caffeate,
and decyl caffeate to the growth medium decreased the
viability of A549 cells ( p < 0.05). The IC50 (a concentration at
which cell viability is 50% of control) values of octyl caffeate,
phenylpropyl caffeate, and decyl caffeate on A549 cells for 24
hours were 79.0 ± 1.0 mM, >100 mM, and 83.2 ± 1.5 mM,
respectively. The IC50 values of octyl caffeate, phenylpropyl
caffeate, and decyl caffeate on A549 cells for 48 hours were
54.2 ± 10.1 mM, 80.2 ± 1.3 mM, and 74.9 ± 2.1 mM,
respectively. These results indicate that octyl caffeate and
decyl caffeate have the greatest viability inhibition of A549
cells of all caffeate derivatives tested. Therefore, octyl caffeate
and decyl caffeate were selected for all subsequent studies.3.2. Effects of octyl caffeate and decyl caffeate on cell
apoptosis in A549 cellsProgrammed cell death is characterized by a specific
sequence of morphology changes including cell shrinkage,
Table 1
Effects of octyl caffeate, phenylpropyl caffeate, and decyl caffeate on the cell viability of A549 human lung carcinoma cells.a
Cell viability (% of control) Caffeate derivatives (mM)
0 10 25 50 100
24 h
Octyl caffeate 100.0 ± 6.1 83.2 ± 1.5* 80.4 ± 3.7* 79.1 ± 1.5* 28.8 ± 2.3*
Phenylpropyl caffeate 100.0 ± 3.1 98.3 ± 6.9 105.1 ± 6.0 106.0 ± 6.5 50.9 ± 14.5*
Decyl caffeate 100.0 ± 7.3 86.5 ± 3.7* 88.1 ± 3.0* 78.0 ± 7.8* 36.0 ± 3.3*
48 h
Octyl caffeate 100.0 ± 3.0 70.8 ± 0.8* 69.7 ± 4.1* 53.5 ± 6.4* 21.6 ± 0.5*
Phenylpropyl caffeate 100.0 ± 3.4 87.1 ± 1.0* 84.5 ± 4.5* 88.5 ± 3.4* 25.3 ± 1.2*
Decyl caffeate 100.0 ± 2.7 81.8 ± 1.8* 85.1 ± 1.2* 74.3 ± 4.2* 25.7 ± 0.3*
Data are presented as mean ± SD (n ¼ 3).
*p < 0.05 indicates significant differences from the control group.
a Cells were treated with 0e100 mM caffeate derivatives for 24 hours and 48 hours.
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tion of apoptotic bodies.13 The effects of octyl caffeate and
decyl caffeate on cell morphology in A549 cells are shown in
Fig. 2. This cell morphology showed that cell shrinkage,
membrane blebbing, and apoptotic body formation were
observed when cells were treated with 50 mM of octyl caffeate
and decyl caffeate (Fig. 2A). The nuclear morphology of un-
treated and treated cells is shown in Fig. 2B by PI staining. PI
staining revealed that apoptotic bodies appeared when the cells
were treated with 50 mM of octyl caffeate and decyl caffeate
for 48 hours.3.3. Effects of octyl caffeate and decyl caffeate on the
mitochondria membrane potential (DJm) in A549 cellsAlterations in mitochondria function have been shown to
play a crucial role in cell apoptosis or programmed cell death.
As shown in Table 2, A549 cells showed significantly
( p < 0.05) decreased mitochondria membrane potential when
treated with 25 mM (6 hours and 12 hours) and 50 mM (12
hours) octyl caffeate. Treatment of A549 cells with 50 mM
decyl caffeate for 6 hours and 12 hours caused the loss of
mitochondria membrane potential ( p < 0.05). Loss of mito-
chondria membrane potential is an early stage of apoptosis
that may further activate the intrinsic pathways of apoptosis.3.4. Octyl caffeate and decyl caffeate induce apoptosis
in A549 cellsThe effects of octyl caffeate and decyl caffeate on the
expression of apoptotic proteins in A549 human lung carci-
noma cells were measured by Western blot analysis. The effect
of decyl caffeate on the levels of Fas, FasL, AIF, Apaf-1, FLIP,
Bcl-2, Bax, Bad, caspase-12, -9, -3, and PARP in A549 cells
for 0 hours, 1 hour, 3 hours, 6 hours, 9 hours, 12 hours, and 24
hours is shown in Fig. 3. The maximal levels of the Fas and
FasL proteins occurred at 3 hours after being treated with octyl
caffeate. However, octyl caffeate did not affect AIF expression
when cells were treated with 25 mM for 0e24 hours. Octyl
caffeate treatment (25 mM, 6e24 hours) resulted in a signifi-
cant increase in the Apaf-1 level. The protein level of FLIPdecreased after treatment of A549 cells with 25 mM of octyl
caffeate for 6e24 hours. The effects of the compounds on the
levels of pro- and anti-Bcl-2 family proteins were also
examined. Treatment of A549 cells with octyl caffeate
increased the protein levels of Bax and Bad and decreased that
of Bcl-2. Furthermore, treatment of A549 cells with octyl
caffeate caused the activation of caspase-12, -9, and -3, which
are associated with the degradation of PARP. We also
demonstrated that decyl caffeate stimulates an increase in the
protein levels of Fas, FasL, and Apaf-1 and a decrease in FLIP
(Fig. 4). Similar to octyl caffeate, treatment of A549 cells with
decyl caffeate changed the levels of pro- and antiapoptotic
Bcl-2 family members and induced the activation of
caspase-12, -9, and -3, which was followed by the cleavage of
PARP.
4. Discussion
Lung cancer is one of the most common types of cancer in
the developed world and is the most lethal of all cancers
worldwide. Caffeate derivatives such as CAPE have been re-
ported to exhibit antioxidant, anti-inflammatory, and anti-
cancer activities.4 However, studies demonstrating the
anticancer effects of caffeate derivatives, including octyl caf-
feate, phenylpropyl caffeate, and decyl caffeate, in human
cancer cells remain inconclusive. Therefore, octyl caffeate,
phenylpropyl caffeate, and decyl caffeate were selected for
testing. The objective of this study was to investigate the ef-
fects of octyl, phenylpropyl, and decyl caffeates on induction
of cell apoptosis and the apoptotic pathway in A549 human
lung carcinoma cells. The induction of apoptosis can provide a
therapeutic strategy for the treatment of cancer.14 Apoptosis or
programmed cell death is characterized by caspase-mediated
specific morphological changes including cell shrinkage,
chromatin condensation, nuclear DNA fragmentation, mem-
brane blebbing, and the release of apoptotic bodies from
apoptotic cells.15 Many studies have indicated that caffeate
derivatives induce apoptosis in human cancer cells, such as
U937 human leukemia cells,7 and SK-MEL-28 human mela-
noma cells.10 However, it is still unclear whether caffeate
derivatives induce apoptosis of human lung cancer cells.
Fig. 2. Effects of octyl caffeate and decyl caffeate on cell morphology in A549 human lung carcinoma cells. (A) Unstained and (B) stained with propidium iodide.
Cells were treated with 50 mM caffeate derivatives for 48 hours.
Table 2
Effects of octyl caffeate and decyl caffeate on mitochondrial membrane po-
tential (DJm) in A549 human lung carcinoma cells.a
DJm (% of control) Caffeate derivatives (mM)
0 25 50
6 h
Octyl caffeate 100.0 ± 0.8 93.7 ± 1.0* 99.2 ± 0.8
Decyl caffeate 100.0 ± 0.9 103.9 ± 0.7 85.9 ± 0.4*
12 h
Octyl caffeate 100.0 ± 0.9 93.8 ± 0.1* 90.5 ± 0.7*
Decyl caffeate 100.0 ± 0.9 101.1 ± 1.2 85.2 ± 0.8*
Data are presented as mean ± SD (n ¼ 3).
*p < 0.05 indicates significant differences from the control group.
a Cells were treated with 0e50 mM caffeate derivatives for 6 hours and 12
hours.
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that octyl caffeate, phenylpropyl caffeate, and decyl caffeate
significantly decreased the cell viability of A549 human lung
carcinoma cells. The results suggest that these caffeate de-
rivatives have cytocidal activity on A549 lung cancer cells.
Octyl caffeate and decyl caffeate have higher cytocidal activity
on A549 cells than phenylpropyl caffeate. Therefore, octyl
caffeate and decyl caffeatewere selected for PI nuclear staining,
mitochondria membrane potential assay, and molecular mech-
anism studies. We further demonstrated that both octyl caffeate
and decyl caffeate have the ability to induce apoptosis of A549
cells. PI staining showed that nuclear condensation and for-
mation of apoptotic bodies occur when cells were treated with
50 mM octyl caffeate and decyl caffeate for 48 hours. Several
indicators for apoptosis were also induced by octyl caffeate and
decyl caffeate, e.g., loss of mitochondria membrane potential,
Fig. 3. Effect of octyl caffeate on protein levels of Fas, FasL, AIF, Apaf-1, FLIP, Bcl-2, Bax, Bad, caspase-12, -9, -3, and PARP in A549 human lung carcinoma
cells. Cells were treated with 25 mM octyl caffeate for 0e24 hours. The relative level of expression of proteins was quantified densitometrically using Image
Analysis Program LabWorks version 4.5 (UVP Imagining Company, Upland, CA, USA) and was calculated according to the b-actin reference bands. AIF ¼ anti-
apoptosis-inducing factor; Apaf-1 ¼ anti-apoptotic protease activating factor-1; FLIP ¼ Fas-associated death-domain-like IL-1b-converting enzyme-inhibitory
protein; PARP ¼ poly (ADP-ribose) polymerase.
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results suggest that these caffeate derivatives have therapeutic
potential against lung cancer via induction of apoptosis, and
octyl caffeate has more anticancer potential than decyl caffeate
and phenylpropyl caffeate.
There are two major apoptotic pathways: the intrinsic
(mitochondria-dependent) and the extrinsic (death receptor-dependent) signaling pathways.16 The intrinsic pathway is
triggered by nonereceptor-mediated stimuli, which upregu-
late proapoptotic proteins (e.g., Bax and Bad) and down-
regulate antiapoptotic proteins (e.g., Bcl-2), and cause an
increase in mitochondria permeability, a loss of mitochondria
potential, and the release of cytochrome c. The released
cytochrome c further binds to Apaf-1, ATP, and caspase-9 to
Fig. 4. Effect of decyl caffeate on protein levels of Fas, FasL, AIF, Apaf-1, FLIP, Bcl-2, Bax, Bad, caspase-12, -9, -3, and PARP in A549 human lung carcinoma
cells. Cells were treated with 25 mM decyl caffeate for 0e24 hours. The relative level of expression of proteins was quantified densitometrically using LabWorks
version 4.5 and was calculated according to the b-actin reference bands. AIF ¼ anti-apoptosis-inducing factor; Apaf-1 ¼ anti-apoptotic protease activating factor-
1; FLIP ¼ Fas-associated death-domain-like IL-1b-converting enzyme-inhibitory protein; PARP ¼ poly (ADP-ribose) polymerase.
541Y.-C. Chen et al. / Journal of the Chinese Medical Association 77 (2014) 535e543form apoptosomes, which in turn activates caspase-3 and
initiates apoptotic degradation.16e24 This study indicated that
treatment of A549 cells with octyl caffeate and decyl caffeate
decreased the mitochondria membrane potential, decreasedthe level of Bcl-2, and increased the levels of Bax, Bad,
Apaf-1, caspase-3, and -9. Moreover, octyl caffeate and decyl
caffeate also induced the cleavage of PARP. The results
suggest that octyl caffeate and decyl caffeate induce
542 Y.-C. Chen et al. / Journal of the Chinese Medical Association 77 (2014) 535e543apoptosis through the mitochondria-dependent pathway in
A549 cells.
By contrast, the extrinsic pathway involves the death-
inducing signaling complex including Fas and its receptor
Fas ligand (FasL), which serves an important role in regulating
the induction of apoptosis in diverse cell types and tissues.25
The binding of FasL to the Fas receptor activates caspase-8,
which in turn activates caspase-3 to initiate apoptotic degra-
dation.16 In this study, the levels of Fas and FasL were
increased by the octyl and decyl caffeates treatments, sug-
gesting that the caffeate derivatives also induce apoptosis
through the death receptor-dependent pathway in A549 cells.
In addition, FLIP, which structurally resembles caspase-8
except that it lacks proteolytic activity, can inhibit death
receptor-mediated apoptosis.26,27 We demonstrated that octyl
caffeate and decyl caffeate stimulate a decrease in the protein
level of FLIP, suggesting that these signal molecules may also
be involved in the caffeate derivatives-mediated induction of
apoptosis. Moreover, there also exists a mitochondria- and
death receptor-independent apoptosis pathway, namely endo-
plasmic reticulum (ER)-induced apoptosis. The central player
in the ER-induced apoptosis pathway is caspase-12 protein.28
Activated caspase-12 can translate from the ER to the cytosol,
where it directly cleaves procaspase-9 and, in turn, activates
the effector caspase, i.e., caspase-3. In this study we found that
the expression of caspase-12 was increased following expo-
sure to caffeate derivatives, suggesting that the ER-induced
apoptotic pathway is also involved in the induction of
apoptosis by caffeate derivatives. Furthermore, it has been
shown that apoptosis can also be induced through regulation of
a caspase-independent mechanism, the AIF-mediated
pathway.29 In this study, the expression of AIF was not
obviously increased following treatment with caffeate de-
rivatives, suggesting that the AIF-mediated pathway is not
involved in caffeate derivative-mediated induction of
apoptosis in A549 cells. Zhou et al30 indicated that TRIM29
and b-catenin may play an important role in the pathogenesis
of lung cancer. However, further examination on the TRIM29
and b-catenin interactions is needed. Syntheses of octyl caf-
feate, phenylpropyl caffeate, and decyl caffeate were semi-
derived from caffeic acid. Chemical properties of octyl
caffeate, phenylpropyl caffeate, and decyl caffeate are as fol-
lows: (1) octyl caffeate: white solid, melting point 98e100C,
molecular weight 292.37, and calculated for C17H24O4; (2)
phenylpropyl caffeate: white solid, melting point 102e103C,
molecular weight 298.33, and calculated for C18H18O4; (3)
decyl caffeate: white solid, melting point 108e109C, mo-
lecular weight 320.42, and calculated for C19H28O4. Ujibe
et al7 found that octyl caffeate induced apoptosis in human
leukemia U937 cells and is six-fold more potent than caffeic
acid phenethyl ester (derived from caffeic acid). Other bio-
logical activities of derivatives of caffeic acid, Hsiao et al31
indicated that octyl caffeate is a potent antioxidant in many
caffeate derivatives. Chou et al32 found that N-2-(4-
bromophenyl) ethyl caffeamide inhibitory effect on MMP-9
expression via NF-kB in human monocytic cells. Weng
et al33 indicated that KS370G (caffeamide derivative)inhibited cardiac hypertrophy via modulations of p-ERK,
p-AKT, and p-GSK3b in pressure-overload mice heart. Ho
et al34 found that caffeic acid phenethyl amide attenuates the
glucose homeostasis in streptozotocin-induced type 1 diabetic
rats.3
In conclusion, the present study showed that octyl caffeate
and decyl caffeate induce apoptosis of A549 human lung
carcinoma cells. Octyl caffeate and decyl caffeate also caused
the loss of mitochondria membrane potential. Octyl caffeate
and decyl caffeate induced apoptosis in A549 cells through
many cellular effects: increased protein levels of Fas, FasL,
and Apaf-1; decreased protein level of FLIP; altered levels of
pro- and antiapoptotic Bcl-2 family members; activation of
caspase-12, -9, and -3; and finally, cleavage of PARP. These
results demonstrate that octyl caffeate and decyl caffeate in-
duces cell apoptosis in A549 human lung carcinoma cells.
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